Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle

1990 ◽  
Vol 122 (2) ◽  
pp. 211-216 ◽  
Author(s):  
Katsuyoshi Seki ◽  
Ichiro Nagata
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Significant Rise ◽  
Dopamine Antagonist ◽  
Endogenous Dopamine ◽  
Serum Lh ◽  
Normal Menstrual Cycle ◽  
Early Follicular Phase ◽  
Adenohypophyseal Hormones ◽  
Normal Women

Abstract To obtain further insight into the role of endogenous dopamine on the adenohypophyseal hormones secretion in normal women, responses of the adenohypophyseal hormones to a dopamine antagonist, metoclopramide, were evaluated in 7 normal women during the early follicular, late follicular and mid-luteal phases of the menstrual cycle. PRL increments following metoclopramide were similar in all phases. During the early and late follicular phases, metoclopramide induced no significant change in circulating LH levels. However, a significant rise in serum LH was observed following metoclopramide during the mid-luteal phase. No significant changes in serum FSH levels were observed after metoclopramide during any of the 3 phases of the cycle. Following metolopramide, serum TSH levels significantly rose in all phases. TSH increments following metoclopramide were significantly lower in the mid-luteal phase than in the early follicular phase. These results suggest that the modulatory effect of endogenous dopamine on adenohypophyseal hormones secretion is variable and selective throughout the normal menstrual cycle.

THE SEQUENCE OF PITUITARY RESPONSES TO SYNTHETIC LUTEINIZING HORMONE RELEASING HORMONE (LH-RH) THROUGHOUT THE NORMAL MENSTRUAL CYCLE

1975 ◽  
Vol 79 (4) ◽  
pp. 625-634 ◽  
Author(s):  
Elwyn M. Grimes ◽  
Irwin E. Thompson ◽  
Melvin L. Taymor
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Lh Surge ◽  
Luteinizing Hormone Releasing Hormone ◽  
Late Luteal Phase ◽  
Normal Menstrual Cycle ◽  
Early Follicular Phase ◽  
Lh Rh ◽  
Late Follicular Phase

ABSTRACT Thirty-one ovulatory women between 20 and 33 years of age were given 150 μg of synthetic LH-RH during different phases of the menstrual cycle. Five patients were studied during the early follicular phase (days 4–7); 10 patients during the late follicular phase (days 9–12); 6 patients during the "LH Surge"; 5 patients during the early luteal phase (days 14–16); 3 patients during mid-luteal phase (days 17–21); and 2 patients during late luteal phase (days 22–27). Oestrogen, progesterone, FSH and LH levels were determined from 30 min prior to LH-RH administration to 90 min thereafter in all cases. LH response to LH-RH increased progressively during the follicular phase. Enhanced pituitary responsiveness to LH-RH occurred at mid-cycle for both LH and FSH and maximum LH responses occurred during the "LH Surge" and early luteal phase. LH responses during the mid and late luteal phases were similar to late follicular phase responses. There were no significant differences between FSH responses during the early follicular, late follicular, mid-luteal and late luteal phases. Maximum pituitary responsiveness appears to occur in a gonadal steroid milieu of high oestrogen levels in association with rising but low progesterone levels. Progesterone or a crucial oestrogen: progesterone ratio may in fact potentiate pituitary release of LH during the early stages of corpus luteum formation. Pituitary responsiveness to LH-RH correlates positively with basal LH and oestrogen levels during the menstrual cycle and with the oestrogen:progesterone ratio during the luteal phase.

Effects of a dopamine antagonist (metoclopramide) on the release of the adenohypophyseal hormones in amenorrhoeic patients with and without hyperprolactinaemia

1982 ◽  
Vol 101 (2) ◽  
pp. 166-170 ◽  
Author(s):  
Katsuyoshi Seki ◽  
Tadashi Uesato ◽  
Koichi Kato
Keyword(s):  
Dopamine Antagonist ◽  
Significant Elevation ◽  
Endogenous Dopamine ◽  
Adenohypophyseal Hormones ◽  
Normal Women ◽  
Insight Into

Abstract. To obtain further insight into the role of endogenous dopamine (DA) on the adenohypophyseal hormones release in amenorrhoeic women, responses of the adenohypophyseal hormones to a DA antagonist, metoclopramide (MCP), were evaluated in 4 normal women, in 9 normoprolactinaemic-amenorrhoeic patients, and in 7 hyperprolactinaemic-amenorrhoeic patients. The hyperprolactinaemic-amenorrhoeic patients were, in the majority, without a demonstrable micro-adenoma. Maximal net increase of prolactin (Prl) after MCP administration were lower (P < 0.01) in hyperprolactinaemic patients compared with those seen in normal women or in normoprolactinaemic-amenorrhoeic patients. Administration of MCP resulted in significant elevation in serum FSH, LH and TSH in hyperprolactinaemic patients, but neither in normal women nor in normoprolactinaemic-amenorrhoeic patients. These findings suggest an increased dopaminergic inhibition of the release of TSH as well as FSH and LH in hyperprolactinaemic-amenorrhoeic patients.

Cortisol, 17α-OH-progesterone and androgen responses to a standardized ACTH-stimulation in different stages of the normal menstrual cycle

1982 ◽  
Vol 100 (3) ◽  
pp. 427-433 ◽  
Author(s):  
N. Kruyt ◽  
R. Rolland
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Adrenal Hyperplasia ◽  
Acth Stimulation Test ◽  
Normal Range ◽  
Acth Stimulation ◽  
Normal Menstrual Cycle ◽  
Early Follicular Phase ◽  
Three Stages

Abstract. The release of cortisol, 17α-OH-progesterone, androstenedione and testosterone during a standardized ACTH-stimulation test was investigated in three different stages of the normal menstrual cycle, to conclude if there is any stage dependency on the release of these hormones. No statistically significant differences were observed between the three stages concerning cortisol and testosterone increase. The increase of androstenedione in the pre-ovulatory stage was significantly higher than that seen during the early follicular phase of the cycle. The increase of 17α-OH-progesterone in the luteal phase was significantly less than that of both the early and late follicular stages of the cycle. Progesterone levels showed a small, but significant increase after ACTH-stimulation, in both the early and late stage of the follicular phase. However, the levels remained within the normal range of the follicular phase. In the luteal phase no increase was seen after ACTH-stimulation. Oestradtiol-17β levels did not change at all after ACTH-stimulation. The stage dependency of androstenedione and 17α-OH-progesterone is discussed. The described stage-dependency different increase of 17α-OH-progesterone release can be of importance when the results of ACTH-tests are evaluated to detect carriers of congenital adrenal hyperplasia.

Excretory Patterns of Urinary Free 11-Hydroxycortico-Steroids and Total Oestrogens Throughout the Normal Menstrual Cycle

1978 ◽  
Vol 15 (1-6) ◽  
pp. 201-202 ◽  
Author(s):  
M. S. Walker ◽  
I. McGilp
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Follicular Phase ◽  
Significant Drop ◽  
Normal Menstrual Cycle ◽  
Normal Women ◽  
Random Fluctuations ◽  
Age Range ◽  
Urine Specimens

Summary The excretion of urinary free 11-hydroxycorticosteroids and total oestrogens was studied daily in morning urine specimens throughout the menstrual cycle of six normal women (age range 18–24 years). The follicular phase of the cycle was characterised by apparently random fluctuations in the excretion of urinary free corticosteroids. However, after the mid-cycle oestrogen peak there occurred a significant drop in corticosteroid excretion, which then rose to a peak eight to 10 days after ovulation and was synchronous with the second oestrogen peak during the luteal phase.

Histamine-induced paradoxical GH response to TRH/GnRH in men and women: Dependence on gonadal steroid hormones

1990 ◽  
Vol 122 (3) ◽  
pp. 354-360 ◽  
Author(s):  
Ulrich Knigge ◽  
Benedikte Thuesen ◽  
Anders Dejgaard ◽  
Birgit Svenstrup ◽  
Paul Bennett
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Normal Subjects ◽  
Gh Secretion ◽  
Early Follicular Phase ◽  
Estrone Level ◽  
Normal Women ◽  
Two Phases ◽  
Normal Men

Abstract A stimulatory GH response to TRH and GnRH occurs frequently in patients with various pathological conditions, but is absent in normal subjects. We have previously shown that histamine induced a paradoxical GH response to TRH in normal men. Since gonadal steroids influence GH secretion, we investigated whether infusion of histamine might induce a GH response to combined administration of TRH (200 μg) and GnRH (100 μg) in 6 normal women during the early follicular and luteal phase of the same menstrual cycle and in 7 normal men. Histamine had no effect on basal GH secretion in men or in women during the two phases of the menstrual cycle. However, compared with saline, histamine induced a GH response to TRH/GnRH in men (GH peak: 5.5 ± 1.0 vs 1.4 ± 0.3 μg/l; p<0.01) and in women during the luteal phase (GH peak: 5.2 ± 1.6 vs 1.5 ± 0.4 μg/l; p<0.025), but not during the early follicular phase of the cycle (GH peak: 1.7 ± 0.5 vs 1.6 ± 0.3 μg/l). In luteal-phase women the GH response to TRH/GnRH correlated with the serum estradiol-17β level (GH area/E2: r=0.98; p<0.005) and the serum estrone level (GH area/E1: r=0.81; p<0.05). In men the GH response to TRH/GnRH did not correlate with estrogen or androgen levels. We conclude that high physiological levels of estrogens are pertinent to the activation of a histamine-induced GH response to TRH/GnRH in women, whereas the role of androgens and estrogens for the induction of the response in men seems more complex. Furthermore, the study indicates that histamine may increase the sensitivity of GH release to nonspecific stimuli.

Pituitary responses to a dopamine antagonist at different times of the day in normal women

1982 ◽  
Vol 100 (4) ◽  
pp. 481-485 ◽  
Author(s):  
F. R. Pérez-López ◽  
C. M. González-Moreno ◽  
M. D. Abós ◽  
J. A. Andonegui ◽  
R. H. Corvo
Keyword(s):  
Serum Prolactin ◽  
Dopamine Antagonist ◽  
Hormonal Changes ◽  
Healthy Women ◽  
Serum Lh ◽  
Normal Women ◽  
The Times ◽  
Serum Tsh

Abstract. In order to determine whether or not pituitary responsiveness to the dopaminergic antagonist clebopride changes during the nyctohemeral cycle, 10 healthy women with regular cycles were given 1 mg of clebopride orally at 09.00 h and 24.00 h with at least a 5 day interval between each test. In addition, 5 of the women were given a placebo instead of clebopride at midnight to evaluate the spontaneous hormonal changes. During the 24.00 h test the women had significantly higher P < 0.05) mean TSH basal levels. Serum prolactin (Prl) increased significantly (P < 0.001) after clebopride administration while these changes did not occur when placebo was used instead of clebopride at midnight. The Prl response to clebopride was qualitatively similar at 09.00 h and at 24.00 h. Clebopride given at midnight induced a significant increase (P < 0.05) in serum TSH while this change did not occur when the drug was given at 09.00 h or when placebo was given at midnight. The administration of clebopride resulted in no discernible alterations in serum LH, FSH or GH in either the 09.00 h or the 24.00 h tests. Thus, Prl responses to clebopride were similar in the morning and at midnight, TSH significantly increased after clebopride at midnight whereas this did not occur when the drug was given in the morning, and no significant changes were induced in LH, FSH or GH at the times studied.

Urinary melatonin, LH, oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptives

1987 ◽  
Vol 116 (1) ◽  
pp. 145-149 ◽  
Author(s):  
Jocelyne Brun ◽  
Bruno Claustrat ◽  
Michel David
Keyword(s):  
Oral Contraceptive ◽  
Menstrual Cycle ◽  
Urinary Excretion ◽  
Oral Contraceptives ◽  
Coefficient Of Variation ◽  
Luteal Phase ◽  
Positive Relationship ◽  
Follicular Phase ◽  
The Other ◽  
Normal Women

Abstract. Nocturnal urinary excretion of melatonin, LH, progesterone and oestradiol was measured by radioimmunoassay in nine normal women during a complete cycle. In addition, these hormonal excretions were studied in two women taking an oral contraceptive. A high within-subject coefficient of variation was observed for melatonin excretion in the two groups. In the nine normal cycling women, melatonin excretion was not decreased at the time of ovulation, but was significantly increased during the luteal phase compared with that of the follicular phase (P < 0.01). These data are consistent with a positive relationship between melatonin and progesterone during the luteal phase. In the two women under an oral contraceptive, melatonin excretion was found within the same range as for the other nine. The results are discussed in terms of pineal investigation in human.

Renal sodium retention does not occur during the luteal phase of the menstrual cycle in normal women

1992 ◽  
Vol 99 (3) ◽  
pp. 247-252 ◽  
Author(s):  
D. L. BISSON ◽  
G. D. DUNSTER ◽  
J. P. O'HARE ◽  
D. HAMPTON ◽  
M. D. PENNEY
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Sodium Retention ◽  
Normal Women

Osmoregulation of thirst and vasopressin during normal menstrual cycle

1988 ◽  
Vol 254 (4) ◽  
pp. R641-R647 ◽  
Author(s):  
T. J. Vokes ◽  
N. M. Weiss ◽  
J. Schreiber ◽  
M. B. Gaskill ◽  
G. L. Robertson
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
Plasma Osmolality ◽  
Free Water ◽  
Urine Osmolality ◽  
Free Water Clearance ◽  
Vasopressin Release ◽  
Plasma Vasopressin ◽  
Normal Menstrual Cycle ◽  
Basal Plasma

Changes in osmoregulation during normal menstrual cycle were examined in 15 healthy women. In 10 women, studied repetitively during two consecutive menstrual cycles, basal plasma osmolality, sodium, and urea decreased by 4 mosmol/kg, 2 meq/l, and 0.5 mM, respectively (all P less than 0.02) from the follicular to luteal phase. Plasma vasopressin, protein, hematocrit, mean arterial pressure, and body weight did not change. In five other women, diluting capacity and osmotic control of thirst and vasopressin release were assessed in follicular, ovulatory, and luteal phases. Responses of thirst and/or plasma vasopressin, urine osmolality, osmolal and free water clearance to water loading, and infusion of hypertonic saline were normal and similar in the three phases. However, the plasma osmolality at which plasma vasopressin and urine osmolality were maximally suppressed as well as calculated osmotic thresholds for thirst and vasopressin release were lower by 5 mosmol/kg in the luteal than in the follicular phase. This lowering of osmotic thresholds for thirst and vasopressin release, which occurs in the luteal phase, is qualitatively similar to that observed in pregnancy and should be taken into account when studying water balance and regulation of vasopressin secretion in healthy cycling women.

A simple, direct radioimmunoassay for salivary progesterone determination during the menstrual cycle.

1986 ◽  
Vol 32 (6) ◽  
pp. 948-951 ◽  
Author(s):  
J Bourque ◽  
J Sulon ◽  
E Demey-Ponsart ◽  
J C Sodoyez ◽  
U Gaspard
Keyword(s):  
Citric Acid ◽  
Menstrual Cycle ◽  
Petroleum Ether ◽  
Luteal Phase ◽  
Deleterious Effect ◽  
Salivary Flow ◽  
Follicular Phase ◽  
Direct Assay ◽  
Normal Women

Abstract We describe a direct radioimmunoassay for progesterone in saliva. Results for extracted and unextracted samples agree well, showing that extraction with petroleum ether is unnecessary. The direct assay is specific and accurate, and detects as little as 2 pg of progesterone per tube (12 pmol/L). Intra- and inter-assay CVs are less than 10%. The correlation between concentrations of progesterone in saliva and plasma is good during the luteal phase of the menstrual cycle (r = 0.78, p less than 0.001, n = 76) but not during the follicular phase. We present mean concentrations of progesterone in saliva and plasma for the whole cycle in 14 normal women. Although citric acid is an effective salivary-flow stimulant, its deleterious effect on the direct radioimmunoassay precludes its use with this assay for monitoring ovulation.

Sign in / Sign up

Export Citation Format

Share Document